FactSet Research Systems (FDS)
(Delayed Data from NYSE)
$404.66 USD
+2.82 (0.70%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $404.67 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$404.66 USD
+2.82 (0.70%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $404.67 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum C VGM
Zacks News
FTI Consulting (FCN) Rides on Low Debt, Investor-Backing Moves
by Zacks Equity Research
FTI Consulting's (FCN) stock is aided by a solid capital position and shareholder-friendly strategies.
Visa's (V) New Program to Boost Digitization of Small Businesses
by Zacks Equity Research
Visa (V) launches the Acceptance Fast Track program with an aim to empower Asia Pacific's small businesses to accept digital payments swiftly.
Reasons Why You Should Bet on Charles River (CRAI) Stock
by Zacks Equity Research
Solid business diversification and investor-friendly moves aid Charles River (CRAI) stock.
Here's Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
WEX's strong organic growth and revenue stability boost the stock.
FactSet (FDS) Stock Up 13.8% in a Year: What's Behind It?
by Zacks Equity Research
Consecutive better-than-expected top and bottom-line performance, shareholder-friendly moves and encouraging guidance have been benefiting the FactSet (FDS) stock.
Zacks Industry Outlook Highlights Paychex, FactSet Research Systems, and ManpowerGroup
by Zacks Equity Research
Paychex, FactSet Research Systems, and ManpowerGroup are part of Industry Outlook article.
3 Dividend-Paying Business Services Stocks You May Count On
by Sanjana Goswami
Here we pick three business service stocks, namely, Paychex (PAYX), FactSet (FDS) and ManpowerGroup (MAN), which have raised dividends amid lingering coronavirus woes.
Down 13.9% in 4 Weeks, Here's Why You Should You Buy the Dip in FactSet (FDS)
by Zacks Equity Research
FactSet (FDS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
IKTSY vs. FDS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
IKTSY vs. FDS: Which Stock Is the Better Value Option?
3 Reasons Why FactSet (FDS) Is a Great Growth Stock
by Zacks Equity Research
FactSet (FDS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Xerox (XRX) Reports Loss in Q1, Revenues Surpass Estimates
by Zacks Equity Research
Xerox's (XRX) first-quarter 2022 revenues decrease year over year.
Omnicom (OMC) Q1 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Omnicom's (OMC) first-quarter 2022 earnings increase while revenues decline year over year.
ManpowerGroup's (MAN) Q1 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
ManpowerGroup's (MAN) first-quarter 2022 earnings and revenues improve year over year.
Reasons to Retain Trane Technologies (TT) in Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) remains focused on improving its business operating system and innovation through business transformation initiatives.
Here's Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
The acquisition of benefitexpress expands WEX's offerings in benefits administration by bringing in a complementary suite of solutions to its Health offerings.
Omnicom (OMC), Firework Team Up for Livestream Shopping Solutions
by Zacks Equity Research
Clients across Omnicom's (OMC) agencies can access Firework's enterprise suite of proprietary short-form video and livestreaming technology post the collaboration.
Paysafe (PSFE) Announces Expansion of Partnership With betPARX
by Zacks Equity Research
The move allows Paysafe (PSFE) to expand its user base by providing payments for the betPARX mobile apps for Pennsylvania and New Jersey.
5 Reasons to Bet on Cross Country Healthcare (CCRN) Stock Now
by Zacks Equity Research
Cross Country Healthcare (CCRN) is currently benefiting from increased demand for healthcare staffing, investments in headcount and technology.
Here's Why Momentum Investors Will Love FactSet Research (FDS)
by Zacks Equity Research
Does FactSet Research (FDS) have what it takes to be a top stock pick for momentum investors? Let's find out.
ABM Industries (ABM) Announces Acquisition of Momentum Support
by Zacks Equity Research
The acquisition is a part of ABM Industries' ELEVATE strategy that focuses on expanding the company's footprint in potential geographies and end-markets through strategic acquisitions.
Here's Why Investors Should Hold Fiserv (FISV) Stock Now
by Zacks Equity Research
Fiserv (FISV) banks on its solid inorganic growth story and a steady share buyback program. However, low liquidity is worrisome.
Accenture (ACN) Set to Invest in Titan Space Technologies
by Zacks Equity Research
Titan is now a participant in Accenture (ACN) Ventures' Project Spotlight.
Here's Why You Should Bet on Interpublic Group (IPG) Stock
by Zacks Equity Research
Interpublic (IPG) continues to invest in technology and internationalize its digital specialist agencies to keep pace with the rapidly evolving media landscape.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
by Zacks Equity Research
IQVIA (IQV) has a growing client base, along with the ability to standardize, organize and integrate its enormous treasure trove of data.
Reasons to Retain Equifax (EFX) Stock in Your Portfolio
by Zacks Equity Research
Equifax's (EFX) ongoing cloud data and technology transformation is aimed at driving innovation and product development.